Center for Financial Planning’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$162 Hold
50
﹤0.01% 638
2026
Q1
$124 Hold
50
﹤0.01% 635
2025
Q4
$103 Hold
50
﹤0.01% 683
2025
Q3
$174 Hold
50
﹤0.01% 639
2025
Q2
$110 Hold
50
﹤0.01% 631
2025
Q1
$58 Hold
50
﹤0.01% 690
2024
Q4
$64 Hold
50
﹤0.01% 660
2024
Q3
$171 Hold
50
﹤0.01% 552
2024
Q2
$234 Hold
50
﹤0.01% 562
2024
Q1
$371 Hold
50
﹤0.01% 588
2023
Q4
$507 Hold
50
﹤0.01% 504
2023
Q3
$390 Hold
50
﹤0.01% 502
2023
Q2
$412 Hold
50
﹤0.01% 543
2023
Q1
$363 Hold
50
﹤0.01% 510
2022
Q4
$444 Hold
50
﹤0.01% 512
2022
Q3
$1K Hold
50
﹤0.01% 588
2022
Q2
$1K Hold
50
﹤0.01% 495
2022
Q1
$1K Hold
50
﹤0.01% 497
2021
Q4
$1K Hold
50
﹤0.01% 505
2021
Q3
$2K Hold
50
﹤0.01% 453
2021
Q2
$3K Hold
50
﹤0.01% 436
2021
Q1
$2K Buy
+50
New +$2.85K ﹤0.01% 489

Other funds holding EDIT

Center for Financial Planning's EDIT Position: Q2 2026 in Review

Center for Financial Planning held its Editas Medicine (EDIT) position steady in Q2 2026 at 50 shares worth $162. The position accounts for ﹤0.01% of the portfolio, ranked #638.

Center for Financial Planning first reported a position in EDIT in Q1 2021 and has held it in 22 quarters since. The position peaked at $3K in Q2 2021. 35 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Center for Financial Planning held 50 shares of Editas Medicine worth $162 as of Q2 2026.
  • Center for Financial Planning left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Center for Financial Planning's portfolio in Q2 2026, its #638 holding.
  • Center for Financial Planning first reported a position in Editas Medicine in Q1 2021 and has held it in 22 quarters since.
  • Center for Financial Planning's Editas Medicine position peaked at $3K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Center for Financial Planning's 13F filing for Q2 2026, filed 21 Jul 2026.